# UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON: Development and validation of an alpha-synuclein Seed Amplification Assay using peripheral bodily fluids of patients affected by Parkinson's disease and Dementia with Lewy bodies

**Lab Budget Score:** 55/100

| Field | Value |
|---|---|
| Organization | UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON |
| Location | HOUSTON, TX |
| Project | Development and validation of an alpha-synuclein Seed Amplification Assay using peripheral bodily fluids of patients affected by Parkinson's disease and Dementia with Lewy bodies |
| Project number | 1R61NS151436-01 |
| Mechanism | R61 |
| Institute | National Institute of Neurological Disorders and Stroke |
| Award | $722,153 |
| Awarded | 2026-08-31 |
| Project period | 2026-09-01 to 2028-08-31 |
| UEI | ZUFBNVZ587D4 |

## Why this score
- Award of $400K or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11443945). Last refreshed: 2026-11-04T21:37:56.465Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.